Default company panoramic image
E1835a97 80fc 4769 b473 4f2af23e7da8


pharmaCline's remarkable wound care products solve unmet needs for over 150 million slow healers in the United States. Ready to launch!

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Sioux Falls, SD, USA
  • Currency USD
  • Founded December 2010
  • Employees 8
  • Website

Company Summary

pharmaCline is a pharmaceutical company that offers products to defeat resistant bacteria in topical wounds, and offers unique healing profiles for certain chronic wounds. No other technology is able to revive old and trusted drugs that have been otherwise rendered useless by resistant bacteria. pharmaCline enables an inexpensive solution to these life and limb-threatening diseases- enabling millions of people to afford this medical care.


  • Default avatar
    Steven J. Keough

    Extensive life science C-suite career experience. Considerable knowledge of extremity wound management. Leader of technology teams since graduating Annapolis in 1977. Focused on solving wound care problems in simpler, more effective, and less expensive manner than current failed approaches. Instrumental in growth of public company SurModics market cap 2004-2008 exceeding billion dollar mark. Experienced and focused on growth of bottom line.

  • Default avatar
    Samuel Michini
    Chief Commercial Officer

    26 year professional in pharma Sales & Marketing with several billion dollar products brought to market at leading pharma/biotech companies. Biogen Idec, Inhibitex, Organon, AKZO Nobel, BASF Pharma.

  • Default avatar
    David G. Armstrong, DPM, MD, PhD
    Chair, Wound Repair Advisory Team

    Founder and Medical Director of the Southern Arizona Limb Salvage Alliance at the University of Arizona (Tucson). Dr Armstrong is a world leader on prevention and treatment of diabetic foot problems. His influence on current approaches to medicine has brought relief to thousands of patients. His role in pharmaCline is essential to our mission.


  • Default avatar
    Nixon & Peabody; Lindquist & Vennum; Hogans Lovell
    Default avatar
    Eide Bailly

Previous Investors

  • Default avatar